An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
Clinical trial NCT03915951 · COMPLETED
Trial details
- NCT number
- NCT03915951
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2022-09-22
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.